[go: up one dir, main page]

CN111018800B - A kind of N2-aryl substituted-1,2,4-triazine derivative and its synthesis and application - Google Patents

A kind of N2-aryl substituted-1,2,4-triazine derivative and its synthesis and application Download PDF

Info

Publication number
CN111018800B
CN111018800B CN201811172417.0A CN201811172417A CN111018800B CN 111018800 B CN111018800 B CN 111018800B CN 201811172417 A CN201811172417 A CN 201811172417A CN 111018800 B CN111018800 B CN 111018800B
Authority
CN
China
Prior art keywords
substituted
reaction
internal olefin
molar ratio
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811172417.0A
Other languages
Chinese (zh)
Other versions
CN111018800A (en
Inventor
吴苹
余正坤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN201811172417.0A priority Critical patent/CN111018800B/en
Publication of CN111018800A publication Critical patent/CN111018800A/en
Application granted granted Critical
Publication of CN111018800B publication Critical patent/CN111018800B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses a method for preparing N2Aryl substituted-1, 2, 4-triazine derivatives and synthesis methods thereof. Using S, N-substituted internal olefin and aryl diazonium salt as initial raw material, copper salt as catalyst, in the presence of alkali and oxidant making cyclization in organic solvent to obtain N2Aryl-substituted-1, 2, 4-triazine derivatives. The invention simply and conveniently synthesizes N with potential bioactivity by designing substrate configuration2Aryl-substituted-1, 2, 4-triazine derivatives. The method has the advantages of simple operation, wide substrate range, mild synthesis reaction conditions and diversity of functional groups.

Description

一种N2-芳基取代-1,2,4-三嗪衍生物及其合成和应用A kind of N2-aryl substituted-1,2,4-triazine derivative and its synthesis and application

技术领域technical field

本发明属于化学有机合成技术领域,涉及一种N2-芳基取代-1,2,4-三嗪衍生物及其合成方法。The invention belongs to the technical field of chemical organic synthesis, and relates to an N2 -aryl-substituted-1,2,4-triazine derivative and a synthesis method thereof.

技术背景technical background

1,2,4-三嗪化合物是一类重要的杂环化合物,由于其独特的化学性质和生物活性,在医药、材料及生物学等诸多领域已获得广泛应用,在药物化学中,具有1,2,4-三嗪骨架结构的化合物表现出抗病毒、抗癌、抗菌和抗结核等多种生物活性。目前合成1,2,4-三嗪类化合物主要有以下两种方法:其一为以酰肼为原料,与1,2-二羰基化合物、2-溴代芳基酮或α-重氮基β-酮酸酯反应得到3,6-二取代或3,5,6-三取代1,2,4-三嗪化合物;其二为以N-氨基脒为原料,与1,2-二羰基化合物反应得到3-单取代、3,5-二取代或3,5,6-三取代的1,2,4-三嗪化合物。然而,在合成1,2,4-三嗪化合物方面仍然有很多方面需要解决,例如反应温度高、步骤繁琐及取代基的多样性等问题。目前的合成方法主要得到取代基在C-3、C-5及C-6位的1,2,4-三嗪化合物,合成氮原子上带有取代基的1,2,4-三嗪化合物鲜有报道,目前只有一篇文献报道了经过多步反应合成了N1-取代的1,2,4-三嗪衍生物(J.Org.Chem.2014, 79,314.)。因此,设计和开发条件温和、原料易得、原子经济、简单方便地合成氮原子上带取代基的多取代1,2,4-三嗪衍生物具有广泛的前景。本发明通过设计底物构型,采用S,N-取代内烯烃与芳基重氮盐环化可以简单方便的合成具有潜在生物活性的N2-芳基取代-1,2,4-三嗪衍生物。该方法操作简便,底物范围广、合成反应条件温和、反应产物收率高。1,2,4-Triazine compounds are an important class of heterocyclic compounds. Due to their unique chemical properties and biological activities, they have been widely used in many fields such as medicine, materials and biology. In medicinal chemistry, they have 1 , 2,4-triazine skeleton-structured compounds exhibit various biological activities such as antiviral, anticancer, antibacterial and antituberculosis. At present, there are two main methods for synthesizing 1,2,4-triazine compounds: one is to use hydrazide as raw material, combine with 1,2-dicarbonyl compound, 2-bromoaryl ketone or α-diazo group β-ketoesters react to obtain 3,6-disubstituted or 3,5,6-trisubstituted 1,2,4-triazine compounds; the second is to use N-aminoamidine as raw material, and 1,2-dicarbonyl The compounds are reacted to obtain 3-monosubstituted, 3,5-disubstituted or 3,5,6-trisubstituted 1,2,4-triazine compounds. However, there are still many aspects to be solved in the synthesis of 1,2,4-triazine compounds, such as high reaction temperature, complicated steps and diversity of substituents. The current synthesis methods mainly obtain 1,2,4-triazine compounds with substituents at C-3, C-5 and C-6 positions, and synthesize 1,2,4-triazine compounds with substituents on nitrogen atoms There are few reports, and only one literature reports the synthesis of N 1 -substituted 1,2,4-triazine derivatives through multi-step reactions (J. Org. Chem. 2014, 79, 314.). Therefore, the simple and convenient synthesis of polysubstituted 1,2,4-triazine derivatives with substituents on nitrogen atoms with mild conditions, readily available raw materials, economical atoms, and simple and convenient synthesis has broad prospects. The present invention can simply and conveniently synthesize N 2 -aryl substituted-1,2,4-triazine with potential biological activity by designing the substrate configuration and adopting S,N-substituted internal olefin and aryl diazonium salt cyclization derivative. The method has the advantages of simple operation, wide substrate range, mild synthesis reaction conditions and high reaction product yield.

发明内容SUMMARY OF THE INVENTION

本发明的目的在于提供一种反应条件温和、适应性广、能简单方便地合成具有潜在生物活性的N2-芳基取代-1,2,4-三嗪衍生物的方法。The purpose of the present invention is to provide a method for mild reaction conditions, wide adaptability, simple and convenient synthesis of N 2 -aryl substituted-1,2,4-triazine derivatives with potential biological activity.

为了实现上述目的,本发明的技术方案如下:In order to achieve the above object, technical scheme of the present invention is as follows:

以S,N-取代内烯烃2和芳基重氮盐3为起始原料,铜盐作催化剂,碱和氧化剂存在下,在有机溶剂中环化合成N2-芳基取代-1,2,4-三嗪衍生物1 (反应式1)。反应结束后经过硅胶柱分离纯化进行产物分离和表征,得到 N2-芳基取代的1,2,4-三嗪衍生物1。Using S,N-substituted internal olefin 2 and aryl diazonium salt 3 as starting materials, copper salt as catalyst, in the presence of alkali and oxidant, cyclization in organic solvent to synthesize N 2 -aryl substituted-1,2,4 - Triazine Derivative 1 (Scheme 1). After the reaction, the product was separated and characterized by silica gel column separation and purification to obtain N 2 -aryl substituted 1,2,4-triazine derivative 1.

Figure BDA0001822859880000011
Figure BDA0001822859880000011

技术方案特征在于:The technical solution is characterized by:

1.以S,N-取代内烯烃2为反应物,其取代基为:1. Take S, N-substituted internal olefin 2 as reactant, and its substituent is:

R1选自以下基团:碳原子数为1-5的烷基、苯基或苯环上带有代基的芳环,苯环上带有取代基为甲基、甲氧基、氟、氯、溴、三氟甲基、硝基、腈基、羧基中的1-5种,取代基的个数为1-5个;R 1 is selected from the following groups: an alkyl group with 1-5 carbon atoms, a phenyl group or an aromatic ring with a substituent on the benzene ring, and the substituent on the benzene ring is methyl, methoxy, fluorine, 1-5 kinds of chlorine, bromine, trifluoromethyl, nitro, nitrile and carboxyl groups, and the number of substituents is 1-5;

R2选自以下基团:甲基、乙基或苄基;R 2 is selected from the following groups: methyl, ethyl or benzyl;

R3选自以下基团:酯基、苯基或苯环上带有代基的芳环,苯环上带有取代基为甲基、甲氧基、氟、氯、溴、三氟甲基、硝基、腈基、羧基中的 1-5种,取代基的个数为1-5个;R 3 is selected from the following groups: ester group, phenyl group or aromatic ring with a substituent on the benzene ring, and the substituent on the benzene ring is methyl, methoxy, fluorine, chlorine, bromine, trifluoromethyl , 1-5 kinds of nitro, nitrile, and carboxyl groups, and the number of substituents is 1-5;

R4选自以下基团:氢、甲基或苯基。 R4 is selected from the following groups: hydrogen, methyl or phenyl.

2.以芳基重氮盐3为反应物,其取代基为:2. Take aryl diazonium salt 3 as reactant, and its substituent is:

R5选自以下基团:氢、甲基、甲氧基、氟、氯、溴、三氟甲基、硝基、腈基、羧基;R 5 is selected from the following groups: hydrogen, methyl, methoxy, fluorine, chlorine, bromine, trifluoromethyl, nitro, nitrile, carboxyl;

X选自以下基团:氟、氯、溴、四氟硼酸根。X is selected from the following groups: fluorine, chlorine, bromine, tetrafluoroborate.

3.所述催化剂铜盐为氯化亚铜、溴化亚铜、碘化亚铜、氯化铜、溴化铜、醋酸铜或水合醋酸铜中的一种或二种以上,其中铜盐最好是CuCl2或 CuBr2,S,N-取代内烯烃2与铜盐的摩尔比为1:0.1-1:3.0,优选摩尔比为 1:0.3-1:2.0。3. the catalyst copper salt is one or more of cuprous chloride, cuprous bromide, cuprous iodide, cupric chloride, cupric bromide, cupric acetate or hydrated copper acetate, wherein the copper salt is the most It is preferably CuCl 2 or CuBr 2 , and the molar ratio of S,N-substituted internal olefin 2 to copper salt is 1:0.1-1:3.0, preferably 1:0.3-1:2.0.

4.所述碱为碳酸锂、碳酸钠、碳酸钾、碳酸铯、磷酸钾、叔丁醇钾或叔丁醇锂中的一种或二种以上,S,N-取代内烯烃2与碱的摩尔比为 1:0.2-1:3.0,优选摩尔比为1:0.5-1:3.0。4. the alkali is one or more of lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate, potassium phosphate, potassium tert-butoxide or lithium tert-butoxide, S, N-substituted internal olefin 2 and alkali. The molar ratio is 1:0.2-1:3.0, preferably the molar ratio is 1:0.5-1:3.0.

5.所述氧化剂为过氧化二叔丁基(DTBP)、叔丁基过氧化氢(TBHP)、过氧化苯甲酸叔丁酯(TBPB)、二氯二氰基苯醌(DDQ)、四甲基哌啶氮氧化物(TBPB)、硫代硫酸钠(Na2S2O8)、硫代硫酸钾(K2S2O8)或硫代硫酸铵((NH4)2S2O8)中的一种或二种以上,S,N-取代内烯烃2与氧化剂的摩尔比为1:0.2-1:2.0,优选摩尔比为1:0.5-1:1.0。5. The oxidant is di-tert-butyl peroxide (DTBP), tert-butyl hydroperoxide (TBHP), tert-butyl peroxybenzoate (TBPB), dichlorodicyanobenzoquinone (DDQ), tetramethyl piperidine nitroxide (TBPB), sodium thiosulfate (Na 2 S 2 O 8 ), potassium thiosulfate (K 2 S 2 O 8 ) or ammonium thiosulfate ((NH 4 ) 2 S 2 O 8 ), the molar ratio of the S,N-substituted internal olefin 2 to the oxidant is 1:0.2-1:2.0, preferably the molar ratio is 1:0.5-1:1.0.

6.反应溶剂为甲苯、1,4-二氧六环、1,2-二氯乙烷(DCE)、二氯甲烷 (DCM)、四氢呋喃(THF)、乙腈、乙醇、N,N-二甲基甲酰胺(DMF)或二甲基亚砜(DMSO)中的一种或两种以上的混合物,优选溶剂为非质子极性溶剂乙腈,S,N-取代内烯烃2于反应溶剂中的摩尔浓度为0.05-1.0M。6. The reaction solvent is toluene, 1,4-dioxane, 1,2-dichloroethane (DCE), dichloromethane (DCM), tetrahydrofuran (THF), acetonitrile, ethanol, N,N-dimethylform One or more mixtures of dimethylformamide (DMF) or dimethyl sulfoxide (DMSO), preferably the solvent is the aprotic polar solvent acetonitrile, the moles of S,N-substituted internal olefin 2 in the reaction solvent The concentration is 0.05-1.0M.

7.反应气氛为空气、氩气、氮气或氧气中的一种或两种以上。7. The reaction atmosphere is one or more of air, argon, nitrogen or oxygen.

8.反应时间为0.5-24小时,最佳反应时间为2-6小时。8. The reaction time is 0.5-24 hours, and the optimal reaction time is 2-6 hours.

9.反应温度为25-80℃,最佳反应温度是25-40℃。9. The reaction temperature is 25-80°C, and the optimum reaction temperature is 25-40°C.

10.S,N-取代内烯烃2与芳基重氮盐3的摩尔比为1:1.2-1:3.0。10. The molar ratio of S,N-substituted internal olefin 2 to aryl diazonium salt 3 is 1:1.2-1:3.0.

本发明具有以下优点:The present invention has the following advantages:

1)通过设计底物类型,采用S,N-取代内烯烃和芳基重氮盐可以简单方便的合成N2-芳基取代-1,2,4-三嗪衍生物。1) By designing the substrate type, N 2 -aryl substituted-1,2,4-triazine derivatives can be synthesized simply and conveniently by using S,N-substituted internal alkenes and aryl diazonium salts.

2)反应原料S,N-取代内烯烃化合物和芳基重氮盐具有结构多样性,可以用来合成具有各种取代基的N2-芳基取代-1,2,4-三嗪衍生物。2) The reaction raw materials S,N-substituted internal olefin compounds and aryl diazonium salts have structural diversity and can be used to synthesize N 2 -aryl substituted-1,2,4-triazine derivatives with various substituents .

3)反应条件温和、操作简便、产物收率高且底物适用范围广。3) The reaction conditions are mild, the operation is simple, the product yield is high, and the substrate is suitable for a wide range.

4)产物具有潜在生物活性。4) The product has potential biological activity.

总之,本发明利用S,N-取代内烯烃和芳基重氮盐环化高效合成N2-芳基取代-1,2,4-三嗪衍生物,反应操作简便、底物范围广、合成反应条件温和。In a word, the present invention utilizes S,N-substituted internal olefin and aryl diazonium salt cyclization to efficiently synthesize N 2 -aryl substituted-1,2,4-triazine derivatives, the reaction operation is simple, the substrate range is wide, and the synthesis The reaction conditions are mild.

具体实施方式Detailed ways

通过下述实施例有助于进一步理解本发明,但本发明的内容并不仅限于此。The following examples are helpful for further understanding of the present invention, but the content of the present invention is not limited thereto.

实施例1Example 1

Figure BDA0001822859880000031
Figure BDA0001822859880000031

向25mL支口管中,依次加入CuBr2(0.09mmol)、K3PO4(0.9mmol)、 K2S2O8(0.15mmol)、S,N-取代内烯烃2a(0.3mmol)、重氮盐3a(0.6mmol)、 CH3CN 3mL,O2气氛下在25℃反应5小时。反应结束后,减压除去溶剂,硅胶柱层析分离(洗脱液为石油醚(60-90℃)/乙酸乙酯,v/v=20:1),得到淡黄色液体目标产物1a(90mg,收率75%)。目标产物通过核磁共振谱和高分辨质谱测定得到确认。Into a 25 mL branched tube, CuBr 2 (0.09 mmol), K 3 PO 4 (0.9 mmol), K 2 S 2 O 8 (0.15 mmol), S,N-substituted internal olefin 2a (0.3 mmol), heavy Nitrogen salt 3a (0.6 mmol), CH 3 CN 3 mL, react at 25° C. for 5 hours under O 2 atmosphere. After the reaction, the solvent was removed under reduced pressure and separated by silica gel column chromatography (eluent was petroleum ether (60-90°C)/ethyl acetate, v/v=20:1) to obtain the target product 1a (90 mg) as a pale yellow liquid. , the yield is 75%). The target product was confirmed by nuclear magnetic resonance spectroscopy and high-resolution mass spectrometry.

实施例2Example 2

Figure BDA0001822859880000032
Figure BDA0001822859880000032

反应步骤与操作同实施例1,与实施例1不同之处在于,催化剂为氯化铜。停止反应,经后处理得到目标产物1a(86mg,收率72%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the catalyst is copper chloride. The reaction was stopped, and the target product 1a (86 mg, yield 72%) was obtained after post-treatment.

实施例3Example 3

Figure BDA0001822859880000033
Figure BDA0001822859880000033

反应步骤与操作同实施例1,与实施例1不同之处在于,碱为K2CO3。停止反应,经后处理得到目标产物1a(82mg,收率68%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the base is K 2 CO 3 . The reaction was stopped, and the target product 1a (82 mg, yield 68%) was obtained after post-treatment.

实施例4Example 4

Figure BDA0001822859880000034
Figure BDA0001822859880000034

反应步骤与操作同实施例1,与实施例1不同之处在于,氧化剂为 Na2S2O8。停止反应,经后处理得到目标产物1a(78mg,收率65%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the oxidant is Na 2 S 2 O 8 . The reaction was stopped, and the target product 1a (78 mg, yield 65%) was obtained after post-treatment.

实施例5Example 5

Figure BDA0001822859880000041
Figure BDA0001822859880000041

反应步骤与操作同实施例1,与实施例1不同之处在于,反应气氛为空气。停止反应,经后处理得到目标产物1a(80mg,收率67%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the reaction atmosphere is air. The reaction was stopped, and the target product 1a (80 mg, yield 67%) was obtained after post-treatment.

实施例6Example 6

Figure BDA0001822859880000042
Figure BDA0001822859880000042

反应步骤与操作同实施例1,与实施例1不同之处在于,反应溶剂为 DCE。停止反应,经后处理得到目标产物1a(70mg,收率58%)。The reaction steps and operations are the same as in Example 1, and the difference from Example 1 is that the reaction solvent is DCE. The reaction was stopped, and the target product 1a (70 mg, yield 58%) was obtained after post-treatment.

实施例7Example 7

Figure BDA0001822859880000043
Figure BDA0001822859880000043

反应步骤与操作同实施例1,与实施例1不同之处在于,反应溶剂为 THF。停止反应,经后处理得到目标产物1a(66mg,收率55%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the reaction solvent is THF. The reaction was stopped, and the target product 1a (66 mg, yield 55%) was obtained after post-treatment.

实施例8Example 8

Figure BDA0001822859880000044
Figure BDA0001822859880000044

反应步骤与操作同实施例1,与实施例1不同之处在于,反应温度为 35℃。停止反应,经后处理得到目标产物1a(90mg,收率75%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the reaction temperature is 35°C. The reaction was stopped, and the target product 1a (90 mg, yield 75%) was obtained after post-treatment.

实施例9Example 9

Figure BDA0001822859880000045
Figure BDA0001822859880000045

反应步骤与操作同实施例1,与实施例1不同之处在于,反应时间为3 h。停止反应,经后处理得到目标产物1a(72mg,收率60%)。The reaction steps and operations were the same as those in Example 1, and the difference from Example 1 was that the reaction time was 3 h. The reaction was stopped, and the target product 1a (72 mg, yield 60%) was obtained after post-treatment.

实施例10Example 10

反应步骤与操作同实施例1,与实施例1不同之处在于,2a与3a的摩尔比为1:1.5。停止反应,经后处理得到目标产物1a(84mg,收率70%)。The reaction steps and operations are the same as in Example 1, and the difference from Example 1 is that the molar ratio of 2a to 3a is 1:1.5. The reaction was stopped, and the target product 1a (84 mg, yield 70%) was obtained after post-treatment.

实施例11Example 11

反应步骤与操作同实施例1,与实施例1不同之处在于,2a与CuBr2的摩尔比为1:1.0。停止反应,经后处理得到目标产物1a(92mg,收率77%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the molar ratio of 2a to CuBr 2 is 1:1.0. The reaction was stopped, and the target product 1a (92 mg, yield 77%) was obtained after post-treatment.

实施例12Example 12

反应步骤与操作同实施例1,与实施例1不同之处在于,2a与K3PO4的摩尔比为1:2.0。停止反应,经后处理得到目标产物1a(72mg,收率60%)。The reaction steps and operations are the same as those of Example 1, and the difference from Example 1 is that the molar ratio of 2a to K 3 PO 4 is 1:2.0. The reaction was stopped, and the target product 1a (72 mg, yield 60%) was obtained after post-treatment.

实施例13Example 13

反应步骤与操作同实施例1,与实施例1不同之处在于,2a与K2S2O8的摩尔比为1:1.0。停止反应,经后处理得到目标产物1a(74mg,收率62%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the molar ratio of 2a to K 2 S 2 O 8 is 1:1.0. The reaction was stopped, and the target product 1a (74 mg, yield 62%) was obtained after post-treatment.

实施例14Example 14

Figure BDA0001822859880000051
Figure BDA0001822859880000051

反应步骤与操作同实施例1,与实施例1不同之处在于,重氮盐为3b。停止反应,经后处理得到目标产物1b(97mg,收率70%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the diazonium salt is 3b. The reaction was stopped, and the target product 1b (97 mg, yield 70%) was obtained after post-treatment.

实施例15Example 15

Figure BDA0001822859880000052
Figure BDA0001822859880000052

反应步骤与操作同实施例1,与实施例1不同之处在于,S,N-取代内烯烃为2b。停止反应,经后处理得到目标产物1c(89mg,收率72%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the S,N-substituted internal olefin is 2b. The reaction was stopped, and the target product 1c (89 mg, yield 72%) was obtained after post-treatment.

实施例16Example 16

Figure BDA0001822859880000053
Figure BDA0001822859880000053

反应步骤与操作同实施例1,与实施例1不同之处在于,S,N-取代内烯烃为2c。停止反应,经后处理得到目标产物1d(88mg,收率70%)。The reaction steps and operations are the same as those of Example 1, and the difference from Example 1 is that the S,N-substituted internal olefin is 2c. The reaction was stopped, and the target product 1d (88 mg, yield 70%) was obtained after post-treatment.

实施例17Example 17

Figure BDA0001822859880000054
Figure BDA0001822859880000054

反应步骤与操作同实施例1,与实施例1不同之处在于,S,N-取代内烯烃为2d。停止反应,经后处理得到目标产物1e(100mg,收率68%)。The reaction steps and operations are the same as those in Example 1, and the difference from Example 1 is that the S,N-substituted internal olefin is 2d. The reaction was stopped, and the target product 1e (100 mg, yield 68%) was obtained after post-treatment.

实施例18Example 18

Figure BDA0001822859880000055
Figure BDA0001822859880000055

反应步骤与操作同实施例1,与实施例1不同之处在于,S,N-取代内烯烃为2e。停止反应,经后处理得到目标产物1f(108mg,收率77%)。The reaction steps and operations are the same as those of Example 1, and the difference from Example 1 is that the S,N-substituted internal olefin is 2e. The reaction was stopped, and the target product 1f (108 mg, yield 77%) was obtained after post-treatment.

应用例1Application example 1

Figure BDA0001822859880000061
Figure BDA0001822859880000061

具体过程为:称取1a(80mg,0.2mmol),NH2NH2·H2O(120uL,2.0mmol, 85%),加入到25mL封管中,加入甲苯2mL,放入120℃油浴中反应7d。反应完全后,冷却至室温,减压旋蒸,除去溶剂,之后柱层析(石油醚(60-90 ℃)/乙酸乙酯=20:1,v/v)得到白色固体产物4a(58mg,收率79%)。The specific process is as follows: Weigh 1a (80 mg, 0.2 mmol), NH 2 NH 2 ·H 2 O (120 uL, 2.0 mmol, 85%), add it to a 25 mL sealed tube, add 2 mL of toluene, and put it in a 120°C oil bath Reaction 7d. After the reaction was completed, it was cooled to room temperature, evaporated under reduced pressure, and the solvent was removed, followed by column chromatography (petroleum ether (60-90 °C)/ethyl acetate=20:1, v/v) to obtain a white solid product 4a (58 mg, yield 79%).

典型化合物表征数据Typical Compound Characterization Data

化合物1a:淡黄色液体。1H NMR(400MHz,CDCl3,23℃)δ7.88,7.54, 7.45,and 7.34(m each,2:1:2:5H,aromatic CH),7.22and 7.13(d each,J=8.6 and 8.5Hz,2:2H,aromatic CH),7.09(s,1H,NCH),2.40and 2.32(s each,3:3 H,2×CH3).13C{1H}NMR(100MHz,CDCl3,23℃)δ189.1(Cq,CO),157.9, 141.1,137.85,137.80,135.4,and 134.5(Cq),132.0,130.4,130.1,129.0,128.7, 127.9,126.1,and 117.6(aromatic CH),74.1(NCH),20.9and 13.4(CH3). HRMS Calcd for C24H22N3OS[M+H]+:400.1484;Found:400.1487。Compound 1a: pale yellow liquid. 1 H NMR (400MHz, CDCl 3 , 23°C) δ 7.88, 7.54, 7.45, and 7.34 (m each, 2:1:2:5H, aromatic CH), 7.22 and 7.13 (d each, J=8.6 and 8.5 Hz, 2:2H, aromatic CH), 7.09(s, 1H, NCH), 2.40 and 2.32(s each, 3:3 H, 2×CH 3 ). 13 C{ 1 H}NMR (100MHz, CDCl 3 , 23℃)δ189.1(Cq,CO),157.9,141.1,137.85,137.80,135.4,and 134.5(Cq),132.0,130.4,130.1,129.0,128.7, 127.9,126.1,and 117.6(aromatic CH),74.1 (NCH), 20.9 and 13.4 ( CH3 ). HRMS Calcd for C24H22N3OS [ M +H] + : 400.1484 ; Found: 400.1487.

Claims (6)

1. N2-a process for the synthesis of aryl-substituted-1, 2, 4-triazine derivatives, characterized in that:
s, N-substituted internal olefin 2 and aryl diazonium salt 3 are used as initial raw materials to synthesize N by cyclization in an organic solvent in the presence of a catalyst, alkali and an oxidant2-aryl substituted-1, 2, 4-triazine derivative 1;
the catalyst is one or two of cupric chloride and cupric bromide; the alkali is one or two of potassium carbonate and potassium phosphate, the oxidant is one or two of sodium thiosulfate and potassium thiosulfate, and the reaction solvent is one or a mixture of more than two of 1, 2-dichloroethane, tetrahydrofuran and acetonitrile;
The synthetic route is shown as follows,
Figure 926129DEST_PATH_IMAGE001
wherein R is1Selected from the following groups: phenyl or a benzene ring with substituent groups on the benzene ring, wherein the substituent groups on the benzene ring are 1-5 of methyl, methoxy, fluorine, chlorine, bromine and trifluoromethyl;
R2selected from the following groups: methyl, ethyl or benzyl;
R3selected from the following groups: phenyl or a benzene ring with substituent groups on the benzene ring, wherein the substituent groups on the benzene ring are 1-5 of methyl, methoxy, fluorine, chlorine, bromine and trifluoromethyl;
R4selected from the following groups: hydrogen, methyl;
R5selected from the following groups: hydrogen, methyl, fluorine, chlorine, bromine, trifluoromethyl;
x is selected from the following groups: tetrafluoroborate radical.
2. A method of synthesis according to claim 1, characterized in that:
the molar ratio of the S, N-substituted internal olefin 2 to the catalyst is 1:0.1-1: 3.0; the molar ratio of the S, N-substituted internal olefin 2 to the base is 1:0.2-1: 3.0; the molar ratio of the S, N-substituted internal olefin 2 to the oxidant is 1:0.2-1: 2.0; the molar ratio of the S, N-substituted internal olefin 2 to the aryl diazonium salt 3 is 1:1.2-1: 3.0;
the molar concentration of the S, N-substituted internal olefin 2 in the reaction solvent is 0.05-1.0M; the reaction solvent is acetonitrile;
the reaction atmosphere is one or more than two of air, argon, nitrogen or oxygen; the reaction time is 0.5 to 24 hours; the reaction temperature is 25-80 ℃.
3. A method of synthesis according to claim 2, characterized in that: the molar ratio of the S, N-substituted internal olefin 2 to the catalyst is 1:0.3 to 1: 2.0.
4. A method of synthesis according to claim 2, characterized in that: the molar ratio of the S, N-substituted internal olefin 2 to the base is from 1:0.5 to 1: 3.0.
5. A method of synthesis according to claim 2, characterized in that: the molar ratio of the S, N-substituted internal olefin 2 to the oxidant is 1:0.5 to 1: 1.0.
6. A method of synthesis according to claim 2, characterized in that: the reaction time is 2-6 hours; the reaction temperature is 25-40 ℃.
CN201811172417.0A 2018-10-09 2018-10-09 A kind of N2-aryl substituted-1,2,4-triazine derivative and its synthesis and application Active CN111018800B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811172417.0A CN111018800B (en) 2018-10-09 2018-10-09 A kind of N2-aryl substituted-1,2,4-triazine derivative and its synthesis and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811172417.0A CN111018800B (en) 2018-10-09 2018-10-09 A kind of N2-aryl substituted-1,2,4-triazine derivative and its synthesis and application

Publications (2)

Publication Number Publication Date
CN111018800A CN111018800A (en) 2020-04-17
CN111018800B true CN111018800B (en) 2022-06-28

Family

ID=70190579

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811172417.0A Active CN111018800B (en) 2018-10-09 2018-10-09 A kind of N2-aryl substituted-1,2,4-triazine derivative and its synthesis and application

Country Status (1)

Country Link
CN (1) CN111018800B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115215836A (en) * 2021-04-16 2022-10-21 中国科学院大连化学物理研究所 A kind of water-soluble sulfonate arylbistriazinepyridine derivative and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Copper(II)-Catalyzed C-H Nitrogenation/Annulation Cascade of Ketene N,S-Acetals with Aryldiazonium Salts: A Direct Access to N2-Substituted Triazole and Triazine Derivatives;Ping Wu等;《Org.Lett.》;20191212;第22卷;310-315 *
One-Pot Acid-Catalyzed Ring-Opening/Cyclization/Oxidation of Aziridines with N-Tosylhydrazones: Access to 1,2,4-Triazines;Lorene Crespin等;《Org.Lett.》;20170215;第19卷;1084-1087 *
Synthesis of 6-hydrazino-3,4-dimethyl-1H-pyrazolo[3,4-d]pyrimidine and its application for the construction of a pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidine system;A.V.Komkov等;《Russian Chemical Bulletin, International Edition》;20130531;第62卷(第5期);1248-1254 *

Also Published As

Publication number Publication date
CN111018800A (en) 2020-04-17

Similar Documents

Publication Publication Date Title
CN113774411B (en) Method for electrochemically synthesizing aryl-substituted quinoxaline (ketone) derivative
CN109912606B (en) A kind of synthetic method of pyrimidoindazole compound
CN108658841B (en) Carbazole compound and preparation method thereof
CN114411178A (en) Polysubstituted pyrazole compound and electrochemical synthesis method thereof
CN102285919A (en) Method for preparing 4-fluorinated pyrazole derivative
CN111018800B (en) A kind of N2-aryl substituted-1,2,4-triazine derivative and its synthesis and application
CN102675223B (en) Preparation method for polysubstitution quinazoline and heterocyclic ring pyrimidine derivative
CN106046002B (en) A kind of synthetic method of pyridoimidazo[1,2,3]triazoloquinoline compound
CN111285881A (en) A kind of thieno[3,4-b]indole derivative and its synthesis method
CN109867632B (en) A 1,2,3-triazole derivative and its synthesis and application
CN106187897B (en) Synthesis method of fused ring pyrazole compound
CN105198883A (en) Synthesis method of 11H-indolo [3,2-c] quinoline compounds
CN102675222B (en) Method for preparing multi-substituted quinazoline and heterocyclic pyrimidine derivative
CN115304607A (en) Process for preparing pyrazolopyrimidine derivatives
CN103224498B (en) Two kinds of azoles the novel synthesis of quinazolinone fused heterocycle
CN106496124B (en) A kind of preparation method of pyrazole compound
CN106588668A (en) 2-bromine-5-nitro-1,2,3,4-tetrahydro-1,4-methano-naphthalene-9-phenol and preparation method thereof
CN107382769B (en) A kind of preparation method of 1-aryl-3-azido-4,4,4-trifluoro-1-butene compound
CN114835713A (en) Synthesis method of 7-methylpyrazolopyrimidine compound
CN112920129B (en) 1,2, 3-triazole-2-oxide and preparation method thereof
CN108218774B (en) A kind of 2-pyrazoline derivative and its synthesis
CN111269165A (en) Synthetic method of 3-arylsulfonyl indole derivative
CN115433143B (en) Method for synthesizing isothiazolinone compound
CN103275008B (en) 3,4,5-trisubstituted pyrazole compounds and preparation method thereof
CN104262268B (en) A kind of synthetic method of 2-itrile group quinoxaline compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant